PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27174003-9	2016	Treatment with metformin reduced the expression of GFAP, Iba-1 (astrocyte and microglial markers) and the inflammation markers (p-IKB, IL-1 and VEGF), while enhancing p-AMPK and eNOS levels and increasing neuronal survival (Fox-1 and NeuN).	Metformin	15-24	induction of brown adipocytes 1	Mus musculus	57-62	
34570348-6	2021	In addition, metformin therapy significantly alleviated reactive microgliosis and astrogliosis in the corpus callosum, as measured by Iba-1 and GFAP staining.	Metformin	13-22	induction of brown adipocytes 1	Mus musculus	134-139	
34890997-11	2022	Metformin and fluoxetine also reduced IBA-1 and GFAP positive cells in the hippocampus.	Metformin	0-9	induction of brown adipocytes 1	Mus musculus	38-43